Advertisement
Screener

ENDRA LIFE SCIENCES INC. (NDRA) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

1.0 / 5 stars · 9/44 Roast Me

ENDRA LIFE SCIENCES INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

ENDRA LIFE SCIENCES INC. (NDRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 27 shares for the 12-month period ending 2024-12-31, per its 10-K/A filed 2025-04-07.

Financial Statements › Shareholders' Equity

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-04-07

  • ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was 0.00 shares.
  • ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was -55.32K shares, a 22227.60% decline year-over-year.
  • ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-06-30 was 0.00 shares.
  • ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-03-31 was 55.35K shares, a 79.79% decline year-over-year.
  • ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 27.00 shares, a 99.99% decline from fiscal 2023.
  • ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 274.13K shares, a 93.08% increase from fiscal 2022.
  • ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 141.97K shares, a 92.25% decline from fiscal 2021.
  • ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 1.83M shares, a 458.68% increase from fiscal 2020.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month
2024-12-310.00 shares
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-04-07
-55.32K shares
derived: sum of 2 quarters · filed 2025-04-07
-55.32K shares
derived: sum of 3 quarters · filed 2025-04-07
27.00 shares
10-K/A · filed 2025-04-07
2024-09-30-55.32K shares
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-11-21
-55.32K shares
derived: sum of 2 quarters · filed 2024-11-21
27.00 shares
10-Q/A · filed 2024-11-21
27.00 shares
derived: sum of 4 quarters · filed 2024-11-21
2024-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
55.35K shares
10-Q · filed 2024-08-14
55.35K shares
derived: sum of 3 quarters · filed 2024-08-14
55.60K shares
derived: sum of 4 quarters · filed 2024-08-14
2024-03-3155.35K shares
10-Q · filed 2024-05-14
55.35K shares
derived: sum of 2 quarters · filed 2024-05-14
55.60K shares
derived: sum of 3 quarters · filed 2024-05-14
55.60K shares
derived: sum of 4 quarters · filed 2024-05-14
2023-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
250.00 shares
derived: sum of 2 quarters · filed 2024-03-28
250.00 shares
derived: sum of 3 quarters · filed 2024-03-28
274.13K shares
10-K · filed 2024-03-28
2023-09-30250.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
250.00 shares
derived: sum of 2 quarters · filed 2023-11-14
274.13K shares
10-Q · filed 2023-11-14
-2.39M shares
derived: sum of 4 quarters · filed 2023-11-14
2023-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
273.88K shares
10-Q · filed 2023-08-14
-2.39M shares
derived: sum of 3 quarters · filed 2023-08-14
-2.38M shares
derived: sum of 4 quarters · filed 2023-08-14
2023-03-31273.88K shares
10-Q · filed 2023-05-15
-2.39M shares
derived: sum of 2 quarters · filed 2023-05-15
-2.38M shares
derived: sum of 3 quarters · filed 2023-05-15
-2.34M shares
derived: sum of 4 quarters · filed 2023-05-15
2022-12-31-2.66M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
-2.65M shares
derived: sum of 2 quarters · filed 2023-03-16
-2.61M shares
derived: sum of 3 quarters · filed 2023-03-16
141.97K shares
10-K · filed 2023-03-16
2022-09-3010.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
48.00K shares
derived: sum of 2 quarters · filed 2022-11-14
2.80M shares
10-Q · filed 2022-11-14
2.96M shares
derived: sum of 4 quarters · filed 2022-11-14
2022-06-3038.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
2.79M shares
10-Q · filed 2022-08-15
2.95M shares
derived: sum of 3 quarters · filed 2022-08-15
2.97M shares
derived: sum of 4 quarters · filed 2022-08-15
2022-03-312.76M shares
10-Q · filed 2022-05-12
2.91M shares
derived: sum of 2 quarters · filed 2022-05-12
2.94M shares
derived: sum of 3 quarters · filed 2022-05-12
4.36M shares
derived: sum of 4 quarters · filed 2022-05-12
2021-12-31153.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
180.00K shares
derived: sum of 2 quarters · filed 2022-03-30
1.61M shares
derived: sum of 3 quarters · filed 2022-03-30
1.83M shares
10-K · filed 2022-03-30
2021-09-3027.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
1.45M shares
derived: sum of 2 quarters · filed 2021-11-15
1.68M shares
10-Q · filed 2021-11-15
1.86M shares
derived: sum of 4 quarters · filed 2021-11-15
2021-06-301.43M shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
1.65M shares
10-Q · filed 2021-08-12
1.83M shares
derived: sum of 3 quarters · filed 2021-08-12
1.85M shares
derived: sum of 4 quarters · filed 2021-08-12
2021-03-31226.00K shares
10-Q · filed 2021-05-17
408.50K shares
derived: sum of 2 quarters · filed 2021-05-17
423.50K shares
derived: sum of 3 quarters · filed 2021-05-17
423.50K shares
derived: sum of 4 quarters · filed 2021-05-17
2020-12-31182.50K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
197.50K shares
derived: sum of 2 quarters · filed 2021-03-25
197.50K shares
derived: sum of 3 quarters · filed 2021-03-25
327.92K shares
10-K · filed 2021-03-25
2020-09-3015.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16
15.00K shares
derived: sum of 2 quarters · filed 2020-11-16
145.42K shares
10-Q · filed 2020-11-16
2.05M shares
derived: sum of 4 quarters · filed 2020-11-16
2020-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
130.42K shares
10-Q · filed 2020-08-14
2.04M shares
derived: sum of 3 quarters · filed 2020-08-14
2.04M shares
derived: sum of 4 quarters · filed 2020-08-14
2020-03-31130.42K shares
10-Q · filed 2020-05-14
2.04M shares
derived: sum of 2 quarters · filed 2020-05-14
2.04M shares
derived: sum of 3 quarters · filed 2020-05-14
2.15M shares
derived: sum of 4 quarters · filed 2020-05-14
2019-12-311.91M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26
1.91M shares
derived: sum of 2 quarters · filed 2020-03-26
2.01M shares
derived: sum of 3 quarters · filed 2020-03-26
2.26M shares
10-K · filed 2020-03-26
2019-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
105.50K shares
derived: sum of 2 quarters · filed 2019-11-13
348.00K shares
10-Q · filed 2019-11-13
633.00K shares
derived: sum of 4 quarters · filed 2019-11-13
2019-06-30105.50K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
348.00K shares
10-Q · filed 2019-08-08
633.00K shares
derived: sum of 3 quarters · filed 2019-08-08
633.00K shares
derived: sum of 4 quarters · filed 2019-08-08
2019-03-31242.50K shares
10-Q · filed 2019-05-14
527.50K shares
derived: sum of 2 quarters · filed 2019-05-14
527.50K shares
derived: sum of 3 quarters · filed 2019-05-14
527.50K shares
derived: sum of 4 quarters · filed 2019-05-14
2018-12-31285.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11
285.00K shares
derived: sum of 2 quarters · filed 2019-03-11
285.00K shares
derived: sum of 3 quarters · filed 2019-03-11
334.79K shares
10-K · filed 2019-03-11
2018-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05
0.00 shares
derived: sum of 2 quarters · filed 2018-11-05
49.79K shares
10-Q · filed 2018-11-05
51.79K shares
derived: sum of 4 quarters · filed 2018-11-05
2018-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13
49.79K shares
10-Q · filed 2018-08-13
51.79K shares
derived: sum of 3 quarters · filed 2018-08-13
61.79K shares
derived: sum of 4 quarters · filed 2018-08-13
2018-03-3149.79K shares
10-Q · filed 2018-05-15
51.79K shares
derived: sum of 2 quarters · filed 2018-05-15
61.79K shares
derived: sum of 3 quarters · filed 2018-05-15
853.01K shares
derived: sum of 4 quarters · filed 2018-05-15
2017-12-312.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20
12.00K shares
derived: sum of 2 quarters · filed 2018-03-20
803.22K shares
derived: sum of 3 quarters · filed 2018-03-20
803.22K shares
10-K · filed 2018-03-20
2017-09-3010.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
801.22K shares
derived: sum of 2 quarters · filed 2017-11-14
801.22K shares
10-Q · filed 2017-11-14
2017-06-30791.22K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07
791.22K shares
10-Q · filed 2017-08-07
2017-03-310.00 shares
10-Q · filed 2017-06-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
IRIDEX CORP (IRIX)United States$0.011B
Nuwellis, Inc. (NUWE)United States$0.003B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Outset Medical, Inc. (OM)United States$0.059B-1.09
Streamex Corp. (STEX)United States$0.089B-0.19
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B